1. Methionine restriction delays senescence and suppresses the senescence-associated secretory phenotype in the kidney through endogenous hydrogen sulfide.
- Author
-
Wang SY, Wang WJ, Liu JQ, Song YH, Li P, Sun XF, Cai GY, and Chen XM
- Subjects
- AMP-Activated Protein Kinases chemistry, AMP-Activated Protein Kinases metabolism, Animals, Caloric Restriction, Cell Line, Cellular Senescence genetics, Cellular Senescence physiology, Cystathionine gamma-Lyase metabolism, Cytokines metabolism, Humans, Indican toxicity, Kidney pathology, Kidney Diseases metabolism, Kidney Diseases pathology, Longevity, Male, Mice, Mice, Inbred C57BL, Phosphorylation, TOR Serine-Threonine Kinases metabolism, Aging metabolism, Cellular Senescence drug effects, Hydrogen Sulfide metabolism, Kidney metabolism, Kidney Diseases diet therapy, Methionine metabolism
- Abstract
Aging is a risk factor for various acute and chronic kidney injuries. Kidney aging is accompanied by the secretion of growth factors, proteases, and inflammatory cytokines, known as the senescence-associated secretory phenotype (SASP). These factors accelerate the aging process and senescence-associated changes. Delaying kidney senescence may prevent acute and chronic kidney injury. Methionine restriction (MR) was found to be an effective intervention for delaying senescence. However, the mechanism of MR remains unclear. In this study, we investigated the effect of MR on the survival rate and renal aging of C57BL/6 mice and examined the relevant mechanisms. MR increased the survival rate and decreased the levels of senescence markers in the aging kidney. Both in vivo and in vitro, MR upregulated the transsulfuration pathway to increase H
2 S production, downregulated senescence markers and the SASP, and activated AMPK. The ability of MR to delay aging was reduced when AMPK was inhibited. These results suggest that MR may slow animal aging and kidney senescence through H2 S production and AMPK pathway activation. Abbreviations : DR: diet restriction; MR: methionine restriction; SASP: senescence-associated secretory phenotype; AL: ad libitum; CKD, chronic kidney disease; AKI: acute kidney disease; TSP: transsulfuration pathway; CGL: cystathionine g-lyase; H2 S: hydrogen sulfide; AMPK: AMP-activated protein kinase; mTOR: mammalian target of rapamycin; IS: indoxyl sulfate; CC: compound C.- Published
- 2019
- Full Text
- View/download PDF